IDFC CORE EQUITY FUND

IDFC CORE EQUITY FUND

(Previously known as IDFC Classic Equity Fund w.e.f. May 28, 2018) Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks

IDFC Core Equity Fund is a diversified equity fund with a large & mid cap bias currently. The focus of the fund is to build a portfolio of Quality companies while being cognizant of the relative valuation.

     FUND PHILOSOPHY*

The fund builds a portfolio of quality stocks with lower relative valuations. Quality (for non-financial stocks) is ascribed on three fronts – conversion of EBIDTA to operating cash – OCF as % of EBIDTA > 33%; Moderate leverage: Debt/EBIDTA <3x; Profitability: EBIDTA / Net operating Assets >30%. Companies that qualify on these three parameters and those which are relatively cheaper within a peer group on P/B basis form part of the ‘quality’ universe. Roughly 50% of the portfolio will comprise of such quality companies; ~30% would be for financial sector and balance 20% would be invested in benchmark heavyweights and themes, which we expect to play out over next 6/12 months. On a tactical basis, the fund may take a part of its overall holding through near month stock futures.

      OUTLOOK

Indian equities continued their upward momentum in August following the trend in global markets, even as India continues to see a sharp increase in daily new Covid-19 cases. In August and over the last 3-month basis, Small Caps significantly outperformed Mid and Large Caps. Since the bottom in March-20, Large, Mid and Small Caps have bounced 50%, 52% and 66% respectively.
Going forward, the pace of economic recovery would depend largely on the extent of local lockdowns on account of spread of Covid-19. Markets seems to have run ahead of fundamentals and are less than 10% lower than all-time highs. Global and domestic liquidity seems to have played a significant part in the sharp up move seen in the markets. Investors should tread with caution as the number of cases and deaths in India continue to rise. Also, earnings uncertainty for FY21 is fairly high with a wide range of analyst estimates.

     FUND FEATURES: (Data as on 31st August'20)

Category: Large & Mid Cap
Monthly Avg AUM: Rs2,175.61 Crores
Inception Date: 9th August 2005
Fund Manager: Mr. Anoop Bhaskar (w.e.f. 30/04/2016)
Benchmark: LargeMidcap 250 TRI (w.e.f. 7th October 2019)
Minimum Investment Amount: Rs5,000/- and any amount thereafter.
Exit Load: If redeemed/switched out within 365 days from the date of allotment:
➧ Upto 10% of investment:Nil,
➧ For remaining investment: 1% of applicable NAV.
If redeemed / switched out after 365 days from date of allotment: Nil. (w.e.f. May 08, 2020)
SIP Frequency Monthly (Investor may choose any day of the month except 29th, 30th and 31st as the date of instalment.)
Options Available: Growth, Dividend - (Payout, Reinvestment and Sweep (from Equity Schemes to Debt Schemes only))
Other Parameters:
Beta: 0.99
R Square: 0.97
Standard Deviation (Annualized): 23.19%

PLANDIVIDEND
RECORD DATE
₹/UNIT NAVNAV
REGULAR 16-Mar-20 1.03 12.0100
14-Mar-19 0.80 15.4200
12-Mar-18 1.01 16.4254
DIRECT 16-Mar-20 0.39 13.7900
14-Mar-19 0.90 17.4700
12-Mar-18 1.13 18.3717
Face Value per Unit (in ₹) is 10
Dividend is not guaranteed and past performance may or may not be sustained in future. Pursuant to payment of dividend, the NAV of the scheme would fall to the extent of payout and statutory levy (as applicable).

PORTFOLIO (31 August 2020)

Name of the Instrument % of NAV
Equity and Equity related Instruments 98.03%
Banks 17.00%
HDFC Bank 5.16%
ICICI Bank 4.65%
Axis Bank 2.95%
Kotak Mahindra Bank 1.56%
State Bank of India 1.44%
RBL Bank 0.71%
The Federal Bank 0.54%
Pharmaceuticals 14.32%
IPCA Laboratories 3.49%
Lupin 2.14%
Sun Pharmaceutical Industries 1.78%
Cadila Healthcare 1.63%
Dr. Reddy's Laboratories 1.59%
Alkem Laboratories 1.36%
Aurobindo Pharma 1.12%
Alembic Pharmaceuticals 0.70%
Indoco Remedies 0.51%
Software 10.63%
Infosys 5.54%
Birlasoft 1.69%
Mastek 1.22%
MphasiS 0.91%
Tech Mahindra 0.74%
KPIT Technologies 0.51%
Auto Ancillaries 6.17%
MRF 2.24%
Apollo Tyres 1.21%
Exide Industries 1.11%
Balkrishna Industries 0.75%
Minda Industries 0.44%
Asahi India Glass 0.43%
Finance 5.56%
ICICI Securities 2.50%
Sundaram Finance 1.48%
Mas Financial Services 0.69%
ICICI Lombard General Insurance Company 0.57%
M&M Financial Services 0.32%
Cement 5.08%
ACC 2.01%
The Ramco Cements 1.61%
Ambuja Cements 1.46%
Industrial Products 4.92%
AIA Engineering 1.99%
Supreme Industries 1.97%
Name of the Instrument % of NAV
Cummins India 0.67%
Bharat Forge 0.30%
Consumer Non Durables 4.81%
Hindustan Unilever 1.77%
ITC 0.91%
Emami 0.89%
Tata Consumer Products 0.77%
Marico 0.47%
Petroleum Products 4.41%
Reliance Industries 3.00%
Bharat Petroleum Corporation 1.41%
Auto 3.98%
Bajaj Auto 1.39%
Mahindra & Mahindra 1.36%
Hero MotoCorp 1.24%
Power 3.36%
Torrent Power 1.86%
Kalpataru Power Transmission 0.89%
Nava Bharat Ventures 0.61%
Telecom - Services 2.55%
Bharti Airtel 2.55%
Retailing 2.50%
Aditya Birla Fashion and Retail 1.28%
Future Retail 0.64%
Future Lifestyle Fashions 0.58%
Construction Project 2.49%
KEC International 1.40%
Larsen & Toubro 1.09%
Consumer Durables 2.33%
Crompton Greaves Consumer Electricals 1.25%
Voltas 1.08%
Gas 2.31%
Mahanagar Gas 1.33%
Gujarat State Petronet 0.98%
Chemicals 2.12%
Deepak Nitrite 2.12%
Hotels, Resorts And Other Recreational Activities 2.01%
The Indian Hotels Company 2.01%
Ferrous Metals 1.48%
Jindal Steel & Power 1.48%
Preference Shares 0.005%
Media & Entertainment 0.005%
Zee Entertainment Enterprises 0.005%
Net Cash and Cash Equivalent 1.96%
Grand Total 100.00%

     SECTOR ALLOCATION

     RISKOMETER

This product is suitable for investors who are seeking*:
• To create wealth over long term
• Investment predominantly in equity and equity related instruments in large and mid-cap companies
*Investors should consult their financial advisors if in doubt about whether the product is suitable for them.


^The benchmark of the fund has been revised from S&P BSE 200 TRI to Nifty LargeMidcap 250 TRI w.e.f. 7th October 2019
Ratios calculated on the basis of 3 years history of monthly data.
The above mentioned is the current strategy of the Fund Manager. However, asset allocation and investment strategy shall be within broad parameters of Scheme Information Document.

MUTUAL FUND INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY.

Contact your Financial Advisor
Call toll free 1800-2-6666-88

Contact your Financial Advisor

Call toll free
1800-2-6666-88

Invest online at www.idfcmf.com

www.facebook.com/idfcamc

@IDFCMF